Published in J Antimicrob Chemother on January 01, 2001
Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother (2005) 2.13
In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs. Antimicrob Agents Chemother (2003) 1.85
Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents. Antimicrob Agents Chemother (2005) 1.35
Antistaphylococcal activity of dalbavancin, an experimental glycopeptide. Antimicrob Agents Chemother (2005) 1.30
High percentage of methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in The Netherlands. J Clin Microbiol (2003) 1.19
Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents. Antimicrob Agents Chemother (2003) 1.16
Antistaphylococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents. Antimicrob Agents Chemother (2004) 0.98
Antipneumococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents. Antimicrob Agents Chemother (2004) 0.95
Antipneumococcal activity of dalbavancin compared to other agents. Antimicrob Agents Chemother (2005) 0.82
Efficacy of linezolid on gram-positive bacterial infection in elderly patients and the risk factors associated with thrombocytopenia. Pak J Med Sci (2013) 0.80
In vitro activity of linezolid against Clostridium difficile. Antimicrob Agents Chemother (2002) 0.77
Determining Linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national release. Antimicrob Agents Chemother (2002) 0.75
Safety Evaluation of the Coagulase-Negative Staphylococci Microbiota of Salami: Superantigenic Toxin Production and Antimicrobial Resistance. Biomed Res Int (2015) 0.75
Antistaphylococcal activity of DX-619 alone and in combination with vancomycin, teicoplanin, and linezolid assessed by time-kill synergy testing. Antimicrob Agents Chemother (2007) 0.75
Antistaphylococcal activity of CB-181963 (CAB-175), an experimental parenteral cephalosporin. Antimicrob Agents Chemother (2004) 0.75
Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med (1992) 8.15
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group. N Engl J Med (1995) 3.04
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill (2008) 2.43
Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother (2001) 2.42
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect (2011) 2.38
Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1995) 2.14
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect (2009) 2.13
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob Agents Chemother (2007) 2.04
[Antimicrobial therapy in exacerbated chronic obstructive pulmonary disease]. Arch Bronconeumol (2002) 2.03
Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. Antimicrob Agents Chemother (2002) 2.00
Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study. Medicine (Baltimore) (2001) 2.00
Visceral leishmaniasis in immunocompromised hosts. Am J Med (1987) 1.99
Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann Intern Med (1989) 1.82
Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci. J Clin Microbiol (2000) 1.78
Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides. Antimicrob Agents Chemother (1994) 1.78
Multiply antibiotic-resistant Streptococcus pneumoniae recovered from Spanish hospitals (1988-1994): novel major clones of serotypes 14, 19F and 15F. Microbiology (1996) 1.69
Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med (1993) 1.69
Evaluation of the upgraded amplified Mycobacterium tuberculosis direct test (gen-probe) for direct detection of Mycobacterium tuberculosis in respiratory and non-respiratory specimens. Diagn Microbiol Infect Dis (2001) 1.60
Evaluation of the MB/BacT mycobacterium detection system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2000) 1.59
Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis. Clin Infect Dis (1998) 1.59
Klebsiella bacteremia: an analysis of 100 episodes. Rev Infect Dis (1985) 1.56
Thalidomide in patients with acquired immunodeficiency syndrome. Arch Intern Med (1992) 1.56
Bloodstream infections in patients with kidney disease: risk factors for poor outcome and mortality. J Hosp Infect (2013) 1.55
Yersinia enterocolitica Septicemia. Am J Clin Pathol (1980) 1.54
Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens. J Clin Microbiol (2008) 1.49
Candida infective endocarditis. Eur J Clin Microbiol Infect Dis (2008) 1.41
Metronidazole resistance in Clostridium difficile is heterogeneous. J Clin Microbiol (2008) 1.38
Role of universal 16S rRNA gene PCR and sequencing in diagnosis of prosthetic joint infection. J Clin Microbiol (2011) 1.37
A conservative procedure for the diagnosis of catheter-related infections. Arch Intern Med (1990) 1.36
Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis (1992) 1.34
[Use of antibiotics in exacerbated chronic obstructive pulmonary disease]. Aten Primaria (2001) 1.31
Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain. Antimicrob Agents Chemother (2007) 1.28
Infections in hairy-cell leukemia. Blood (1978) 1.26
Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Clin Infect Dis (2000) 1.23
Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients. Clin Microbiol Infect (2010) 1.23
Group-C beta-hemolytic streptococcal bacteremia. Diagn Microbiol Infect Dis (1992) 1.22
Infectious osteitis pubis. Urology (1978) 1.22
Group G streptococcal endocarditis. Am J Clin Pathol (1978) 1.22
Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999. Antimicrob Agents Chemother (2001) 1.22
Leuconostoc species as a cause of bacteremia: two case reports and a literature review. Eur J Clin Microbiol Infect Dis (1991) 1.17
Rapid detection of toxigenic Clostridium difficile from stool samples by a nested PCR of toxin B gene. J Hosp Infect (1999) 1.17
Nasal carriage of S. aureus increases the risk of surgical site infection after major heart surgery. J Hosp Infect (2007) 1.17
Group A streptococcal bacteremia. A 10-year prospective study. Medicine (Baltimore) (1997) 1.16
In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates. Antimicrob Agents Chemother (1998) 1.15
Rhodococcus equi infection in transplant recipients: case report and review of the literature. Transplantation (1998) 1.14
Lemierre's disease: postanginal bacteremia and pulmonary involvement caused by Fusobacterium necrophorum. Rev Infect Dis (1989) 1.12
Group B Streptococcus: a cause of urinary tract infection in nonpregnant adults. Clin Infect Dis (1992) 1.11
Molecular analysis of relapse vs re-infection in HIV-positive patients suffering from recurrent Clostridium difficile associated diarrhoea. J Hosp Infect (2001) 1.11
Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin Microbiol Infect (2004) 1.09
Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics. The Spanish Surveillance Group for Respiratory Pathogens. J Antimicrob Chemother (2000) 1.09
Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation. Antimicrob Agents Chemother (2005) 1.09
Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia. Clin Microbiol Infect (2012) 1.09
Coccidioidal meningitis. An analysis of thirty-one cases and review of the literature. Medicine (Baltimore) (1981) 1.07
In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugs. Antimicrob Agents Chemother (2000) 1.06
Postsurgical mediastinitis: a case-control study. Clin Infect Dis (1997) 1.06
Extra-intestinal infections caused by Clostridium difficile. Clin Microbiol Infect (2001) 1.06
Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Spain: a multicentre prevalence study (2002). Clin Microbiol Infect (2007) 1.05
Listeriosis in patients infected with human immunodeficiency virus. Rev Infect Dis (1991) 1.05
In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole. Antimicrob Agents Chemother (2005) 1.03
Evidence of nosocomial Stenotrophomonas maltophilia cross-infection in a neonatology unit analyzed by three molecular typing methods. Infect Control Hosp Epidemiol (1999) 1.03
An improved protocol for pulsed-field gel electrophoresis typing of Clostridium difficile. J Med Microbiol (2005) 1.02
Feculent meningitis: polymicrobial meningitis in colorectal surgery. Diagn Microbiol Infect Dis (2000) 1.02
In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia. J Antimicrob Chemother (2007) 1.01
Bacillus cereus endogenous panophthalmitis. Arch Ophthalmol (1979) 1.00
Group B streptococcus bacteremia in nonpregnant adults. Arch Intern Med (1997) 0.99
BK virus in liver transplant recipients: a prospective study. Transplant Proc (2009) 0.99
High incidence of tuberculosis in renal patients. Eur J Clin Microbiol Infect Dis (1990) 0.99
Management of methicillin-resistant Staphylococcus aureus infections. Clin Microbiol Infect (2009) 0.99
Fluconazole resistance mechanisms in Candida krusei: the contribution of efflux-pumps. Med Mycol (2006) 0.98
Corynebacterium striatum: an undescribed agent of pacemaker-related endocarditis. Clin Infect Dis (1996) 0.97
Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital. Clin Microbiol Infect (2010) 0.97
Cutaneous mucormycosis in a heart transplant patient associated with a peripheral catheter. Eur J Clin Microbiol Infect Dis (1995) 0.97
Staphylococcus aureus carriage among participants at the 13th European Congress of Clinical Microbiology and Infectious Diseases. Eur J Clin Microbiol Infect Dis (2005) 0.97
The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem? Clin Microbiol Infect (2012) 0.96
Direct identification of pathogens from positive blood cultures using matrix-assisted laser desorption-ionization time-of-flight mass spectrometry. Clin Microbiol Infect (2013) 0.95
In vitro activity of new quinolones against Clostridium difficile. J Antimicrob Chemother (2001) 0.95
Evolution of penicillin and erythromycin co-resistance in Streptococcus pneumoniae in Spain. Int J Antimicrob Agents (2003) 0.95
Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit. Int J Antimicrob Agents (2000) 0.95
Characterization of Mycobacterium tuberculosis Beijing isolates from the Mediterranean area. BMC Microbiol (2010) 0.95
Infection of hickman catheter by Pseudomonas (formerly flavimonas) oryzihabitans traced to a synthetic bath sponge. J Clin Microbiol (2000) 0.94
[Epidemic outbreak of methicillin-resistant Staphylococcus aureus in a general hospital. Preliminary report]. Enferm Infecc Microbiol Clin (1991) 0.94
Evaluation of aztreonam in the treatment of severe bacterial infections. Antimicrob Agents Chemother (1985) 0.94
Acute and chronic adult osteomyelitis and prosthesis-related infections. Baillieres Best Pract Res Clin Rheumatol (1999) 0.93
Enterobacter bacteremia. An analysis of 50 episodes. Arch Intern Med (1985) 0.93
Transmission permeability of tuberculosis involving immigrants, revealed by a multicentre analysis of clusters. Clin Microbiol Infect (2009) 0.93
Antimicrobial resistance of Salmonella isolates in a Spanish hospital. Antimicrob Agents Chemother (1993) 0.92
Aeromonas peritonitis. Clin Infect Dis (1994) 0.92
Heterogeneous antimicrobial resistance patterns in polyclonal populations of coagulase-negative staphylococci isolated from catheters. J Clin Microbiol (2000) 0.92
Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis (1995) 0.92
A novel method for the rapid and prospective identification of Beijing Mycobacterium tuberculosis strains by high-resolution melting analysis. Clin Microbiol Infect (2011) 0.91
Resistance of anaerobic bacteria to antimicrobial agents. Rev Infect Dis (1991) 0.91
Impact of the BACTEC NR system in detecting Candida fungemia. J Clin Microbiol (1990) 0.91
Is there an ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? The Spanish Surveillance Group for Respiratory Pathogens. J Clin Microbiol (1999) 0.91
Nonsurgical cure of isolated cerebral mucormycosis in an intravenous drug user. Eur J Clin Microbiol Infect Dis (1996) 0.91
Streptococcus pneumoniae skin and soft tissue infections: characterization of causative strains and clinical illness. Eur J Clin Microbiol Infect Dis (2007) 0.91
Endocarditis caused by Corynebacterium group D2. J Infect (1991) 0.90
Value of superficial cultures for prediction of catheter-related bloodstream infection in long-term catheters: a prospective study. J Clin Microbiol (2013) 0.90
Laboratory diagnosis of Clostridium difficile infection in Spain: a population-based survey. J Hosp Infect (2011) 0.90
Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV+ patients. Clin Microbiol Infect (2011) 0.90
The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections. Transplant Proc (2007) 0.90